WebCurrent and historical p/e ratio for Fulcrum Therapeutics (FULC) from 2024 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the … WebThe best-performing ETF in the past 12 months with FULC as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 70.70%. ETF s with the most FULC …
Fulcrum Therapeutics, Inc. (FULC) 10K Annual Reports & 10Q SEC …
WebApr 5, 2024 · FULC Fulcrum Therapeutics Inc Current Report Filing (8-k) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).. Emerging growth company ☒ WebApr 12, 2024 · Their FULC share price forecasts range from $6.00 to $21.00. On average, they predict the company's stock price to reach $10.88 in the next twelve months. This … glasses malone that good
Fulcrum Therapeutics - FULC - Stock Price Today - Zacks
WebNov 8, 2024 · Ticker: FULC CIK: 1680581 Form Type: 10-Q Quarterly Report Accession Number: 0000950170-22-022913 Submitted to the SEC: Tue Nov 08 2024 7:43:53 AM EST Accepted by the SEC: Tue Nov 08 2024 Period: Friday, September 30, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote WebGet Fulcrum Therapeutics Inc (FULC:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebFULC is currently covered by 7 analysts with average potential upside of $11.07 (128.9%) backed by 14 price targets and 49 ratings. Documented since 12-Aug-2024. Analyst's average stock valuation to be materialised ratio is 36.71% with an average time for price targets to be met of 96.57 days. glasses magnify my eyes